Results 91 to 100 of about 28,830 (241)
PLoS ONE, 2011 BackgroundImplication of pharmacogenetic variations and efavirenz pharmacokinetics in concomitant efavirenz based antiviral therapy and anti-tubercular drug induced liver injury (DILI) has not been yet studied.
Getnet Yimer +10 more
doaj +1 more source
Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
Pediatric Health, Medicine and Therapeutics, 2014 Beatriz Larru,1 Jessica Eby,2,3 Elizabeth D Lowenthal2,4,51Department of Pediatrics, Division of Infectious Diseases, 2Department of Pediatrics, Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, 3Villanova University,
Larru B, Eby J, Lowenthal ED
doaj
Brazilian Journal of Pharmaceutical Sciences, 2011 Efavirenz is a reverse transcriptase non analog nucleoside inhibitor used to treat HIV infections. A simple assay method by high performance liquid chromatography was developed and validated for efavirenz tablets. The physical chemical characteristics of
Osnir de Sá Viana +9 more
doaj +1 more source
A Potentially Significant Interaction between Efavirenz and Phenytoin: A Case Report and Review of the Literature [PDF]
, 2005 Sarah Robertson +4 more
openalex +1 more source
O Efavirenz: Relação Estrutura-Atividade e Métodos de Síntese [PDF]
, 2015 Carolina C. P. Costa +4 more
openalex +1 more source
, 2013 8-hydroxyefavirenz (ng/mL) and efavirenz/8-hydroxyefavirenz ratio (MR) was compared between patients who developed concomitant efavirenz-based HAART and rifampicin based anti-tubercular drugs induced liver injury (cases) and those who did not (controls).
Lars Lindquist (316252) +10 more
core +1 more source
Efavirenz Induced Suicidal Death of Human Erythrocytes [PDF]
, 2015 Background/Aims: The reverse transcriptase inhibitor efavirenz utilized for the treatment of human immunodeficiency virus (HIV)-1 infection, triggers suicidal cell death or apoptosis, an effect in part due to interference with mitochondrial potential ...
Abdulla Al Mamun Bhuyan +5 more
core +1 more source
Efavirenz Plasma Concentrations and Cytochrome 2B6 Polymorphisms
, 2010 Background: Interpatient variability in efavirenz concentrations may be due to CYP2B6 genetic polymorphisms. Efavirenz concentration and pharmacogenomic data are scarce in Latino patients.
Jessica C Song +4 more
core +1 more source
, 2016 Aim: The non-nucleoside reverse transcriptase inhibitor efavirenz is one of the most prescribed antiretroviral therapeutics. Efavirenz-containing therapy has become associated with the occurrence of CNS side effects, including sleep disturbances ...
core +1 more source
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients [PDF]
, 2008 Benjamin Young +8 more
openalex +1 more source